EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study

Marilina García-Aranda iD, Desireé Martín-García, Janire Gallejones-Eskubi, Eloísa Urrechaga iD, Josefa Ferreiro iD, Vicente Portugal, Isabel Portillo iD, Marta Jiménez-Toscano iD, Maria Jose Legarreta iD, José María Quintana, Maximino Redondo, Urko Aguirre iD und 1 weitere

Journal of Clinical Medicine · 05.06.2026 · 15 (11) · 4389

DOI: 10.3390/jcm15114389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.06.2026. Verfasst von Marilina García-Aranda und 12 weiteren Autor:innen. Beteiligte Einrichtung: B-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Pl…. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Basque Health Department, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As survival after colorectal cancer (CRC) has improved, an increasing proportion of patients live beyond five years, making long-term outcomes increasingly relevant. In addition to cancer-related mortality, survivors remain at risk of death from other causes influenced by clinical and psychosocial vulnerabilities.

Methods

We conducted a 10-year prospective cohort study including 838 patients with stage I–IV CRC treated in public hospitals in the Basque Country (Spain). Patients were recruited between November 2010 and December 2012 and followed for up to 10 years after surgery. Clinical, sociodemographic, lifestyle, and patient-reported outcomes were collected. Competing risk regression models (Fine-Gray) were used to estimate sub-distribution hazard ratios (sHRs) for CRC-specific and non-CRC mortality, stratified by tumor site and sex.

Results

After 10 years, 40% of patients had died, with 66% of deaths attributable to CRC and 34% to other causes. CRC-specific mortality was mainly driven by tumor-related factors, including advanced stage (stage IV: sHR 7.18, p < 0.001) and residual disease after surgery (R1/R2: sHR 2.68; p < 0.001), with larger effect sizes observed in rectal cancer. In contrast, non-CRC mortality was associated with patient vulnerability, including age ≥75 years (sHR 3.57, p < 0.001), absence of adjuvant chemotherapy (sHR 5.59, p < 0.001), anemia, alcohol consumption, and poor functional status. Patients with rectal cancer and women reported poorer baseline quality of life. Sex-stratified analyses suggested differential patterns of vulnerability, with psychosocial and quality-of-life-related factors appearing more relevant in women, whereas lifestyle and clinical factors appeared more prominent in men.

Conclusions

Long-term mortality in CRC reflects the interplay between tumor-related factors and patient vulnerability. Competing risk models allow a more accurate characterization of cause-specific outcomes and may help identify high-risk subgroups for tailored follow-up and management strategies.

Schlagwörter

Stichwörter der Autor:innen

cancer survivorshipcause-specific mortalitycolorectal cancerlong-term outcomessex differences

Autor:innen und Institutionen

  • B-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
  • Research and Innovation Unit, Hospital Universitario Costa del Sol, 29602 Marbella, Spain.
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010 Málaga, Spain.
  • Research Unit, Osakidetza Basque Health Service, Barrualde-Galdakao Integrated Health Organisation, Galdakao-Usansolo Hospital, 48960 Galdakao, Spain.
  • Biosistemak Institute for Health System Research, Gran Vía, 1, 48001 Bilbao, Spain.

ORCID-Profile: Marilina García-Aranda, Eloísa Urrechaga, Josefa Ferreiro, Isabel Portillo, Marta Jiménez-Toscano, Maria Jose Legarreta, Urko Aguirre

Förderung

  • Instituto de Salud Carlos III
  • Basque Health Department
  • European Union

Zitieren

APA

García-Aranda, M., Martín-García, D., Gallejones-Eskubi, J., Urrechaga, E., Ferreiro, J., Portugal, V., Portillo, I., Jiménez-Toscano, M., Legarreta, M. J., Quintana, J. M., Redondo, M., Aguirre, U., & REDISSEC/CARESS-CCR Group (2026). Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. Journal of Clinical Medicine, 15(11), 4389. https://doi.org/10.3390/jcm15114389

Vancouver

García-Aranda M, Martín-García D, Gallejones-Eskubi J, Urrechaga E, Ferreiro J, Portugal V, et al. Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study. Journal of Clinical Medicine. 2026;15(11):4389. doi:10.3390/jcm15114389

BibTeX
@article{GarcaAranda2026,
  author = {García-Aranda, Marilina and Martín-García, Desireé and Gallejones-Eskubi, Janire and Urrechaga, Eloísa and Ferreiro, Josefa and Portugal, Vicente and Portillo, Isabel and Jiménez-Toscano, Marta and Legarreta, Maria Jose and Quintana, José María and Redondo, Maximino and Aguirre, Urko and REDISSEC/CARESS-CCR Group, REDISSEC/CARESS-CCR Group},
  title = {Ten-Year Outcomes in Colorectal Cancer—Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4389},
  doi = {10.3390/jcm15114389}
}
Kostenlos starten →